Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Novavax Inc (NQ: NVAX )

217.97 USD +17.90 (+8.95%)
Streaming Delayed Price Updated: 1:00 PM EST, Nov 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Novavax Inc

< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
NVAX ALERT: Investors with Substantial Losses Have Opportunity to Lead the Novavax, Inc. Class Action Lawsuit
The suit alleges defendants issued false statements concerning Novavax business and prospects, resulting in its stock trading at inflated prices. 
From Business Wire News Releases
A Terrifying New Variant Could Elude Vaccines — BioNTech Won't Know For Two Weeks
Vaccine stocks Pfizer, BioNTech and Moderna popped Friday as scientists grappled with a new Covid variant first detected in South Africa. 
From Investor's Business Daily
4 Hot Health Care Stocks To Watch Right Now
Tags Market News
From StockMarket.com
3 Small-Cap COVID Stocks With Huge Upside
Three Fool.com contributors are bullish on Beyond Air, Ocugen, and Fulgent Genetics. 
Tags Recent Press Releases XAIR OCGN
From Motley Fool
Why Novavax Was Wilting on Wednesday
Some good news on the regulatory front wasn't enough to make investors happy. 
Tags Market News Recent Press Releases NVAX
From Motley Fool
January 2022 Options Now Available For Novavax (NVAX)
Investors in Novavax, Inc. (NVAX) saw new options become available today, for the January 2022 expiration.. 
Tags Stocks
From Market News Video
Looking At Novavax's Recent Whale Trades
A whale with a lot of money to spend has taken a noticeably bearish stance on Novavax. Looking at options history for Novavax ... 
Tags Market News BZI/UOA Options
From Benzinga
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Novavax, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – NVAX
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Novavax, Inc. (NASDAQ: NVAX) between March 2, 2021 and October 19, 2021, inclusive (the “Class Period”),... 
From Business Wire News Releases
Better Buy: Ocugen or Novavax?
Will either of these hopeful vaccine makers continue to thrash the market? 
Tags NVAX Recent Press Releases OCGN
From Motley Fool
2 Top Biotech Stocks Ready for a Bull Run
Both of these companies have potential catalysts on the way. 
Tags Recent Press Releases NVAX Market News
From Motley Fool
Ones To Watch: Novavax Stock Sees RS Rating Jump To 85
Novavax sees its Relative Strength Rating reach the 80-plus level. 
From Investor's Business Daily
Sum Up The Parts: IYH Could Be Worth $321
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
4 Reasons Pfizer Is Now the Ultimate COVID-19 Growth Stock
There's more to it than being the first to market with its vaccine. 
Tags JNJ MRNA Market News
From Motley Fool
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Novavax, Inc. (NVAX)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming January 11, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or... 
From Business Wire News Releases
NVAX Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Novavax, Inc. Shareholders of Class Action and Lead Deadline: January 11, 2022
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Novavax, Inc. ("Novavax” or the "Company") (NASDAQ: NVAX) and certain of... 
From Business Wire News Releases
Will Novavax Be Worth as Much as Moderna by 2025?
Novavax's vaccine candidate may soon reach commercialization. 
Tags Recent Press Releases NVAX MRNA
From Motley Fool
Ocugen Stock: Bull vs. Bear
There's more to this potential coronavirus vaccine stock than what happens in the next 12 months. 
Tags PFE Recent Press Releases EDIT
From Motley Fool
3 Cutting-Edge Stocks to Buy If There's a Stock Market Crash
Buying companies on the leading edge of innovation during a crash or steep correction can make you a lot richer over the long run. 
Tags ^GSPC Recent Press Releases PLNH/F
From Motley Fool
What Are the Top COVID Plays for 2022?
Here are three COVID-19 stock ideas: a vaccine biotech, a big pharma stock, and an investment in a reopening. 
Tags Recent Press Releases PFE NVAX
From Motley Fool
Novavax Whale Trades Spotted
A whale with a lot of money to spend has taken a noticeably bearish stance on Novavax. Looking at options history for Novavax ... 
Tags Market News BZI/UOA NVAX
From Benzinga
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Novavax, Inc. (NVAX)
Law Offices of Howard G. Smith reminds investors of the upcoming January 11, 2022 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Novavax, Inc.... 
From Business Wire News Releases
LAWSUITS FILED AGAINST ZEV, Z and NVAX - Jakubowitz Law Pursues Shareholders Claims
From ACCESSWIRE
SHAREHOLDER ALERT: HMLP LSPD NVAX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
From ACCESSWIRE
SHAREHOLDER ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Novavax Investors of Securities Fraud Class Action Lawsuit Filed On Their Behalf
Kessler Topaz Meltzer & Check, LLP Reminds Novavax Investors of Securities Fraud Class Action Lawsuit Filed On Their Behalf 
From Business Wire News Releases
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AMRN, FB and NVAX
From ACCESSWIRE
LAWSUITS FILED AGAINST CEI, LSPD And NVAX - Jakubowitz Law Pursues Shareholders Claims
From ACCESSWIRE
5 Biotech Stocks To Check Out In The Stock Market Now
Tags Market News
From StockMarket.com
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of Z, SBTX and NVAX
From ACCESSWIRE
3 Second-Shot Covid Stocks to Buy
InvestorPlace - Stock Market News, Stock Advice & Trading Tips The way 2022 is shaping up off and on the price charts, investors may consider these three Covid stocks to buy for a healthier portfolio.... 
Tags PTON NVAX Market News
From InvestorPlace
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Novavax, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Novavax, Inc. 
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.